Współczesna Onkologia

Chloride intracellular channels engage in head and neck squamous cell carcinoma pathogenesis: a bioinformatic exploration of expression patterns, immune interactions, and oncogenic pathways

  1. Chair and Department of Head and Neck Surgery, Poznan University of Medical Sciences, Poznan, Poland

  2. Department of Head and Neck Surgery, Greater Poland Cancer Centre, Poznan, Poland

  3. Radiobiology Laboratory, Greater Poland Cancer Centre, Poznan, Poland

  4. Doctoral School, Poznan University of Medical Sciences, Poznan, Poland

  5. Greater Poland Center of Digital Medicine, Poznan University of Medical Sciences, Poznan, Poland

  6. Department of Electroradiology, Poznan University of Medical Sciences, Poznan, Poland

Contemp Oncol (Pozn) 2026; 30 (3)

Data publikacji online: 2026/10/19
Article files
Chloride intracellular.pdf WO-02363-2026-02 Supplementary Material CLIC.pdf
  1. Littler DR, Harrop SJ, Goodchild SC, Phang JM, Mynott AV, Jiang L, et al. The enigma of the CLIC proteins: Ion channels, redox proteins, enzymes, scaffolding proteins? FEBS Letters 2010; 584: 2093-2101.
  2. Gururaja Rao S, Ponnalagu D, Patel NJ, Singh H. Three decades of chloride intracellular channel proteins: from organelle to organ physiology. Curr Protoc Pharmacol 2018; 80: 11.21.1–11.21.17.
  3. Gururaja Rao S, Patel NJ, Singh H. Intracellular chloride channels: novel biomarkers in diseases. Front Physiol 2020; 11: 96.
  4. Singh H, Cousin MA, Ashley RH. Functional reconstitution of mammalian ‘chloride intracellular channels’ CLIC1, CLIC4 and CLIC5 reveals differential regulation by cytoskeletal actin. FEBS J 2007; 274: 6306-6316.
  5. Al Khamici H, Brown LJ, Hossain KR, Hudson AL, Sinclair- Burton AA, Ng JPM, et al. Members of the chloride intracellular ion channel protein family demonstrate glutaredoxin-like enzymatic activity. PLoS One 2015; 10: e115699.
  6. Valenzuela SM, Mazzanti M, Tonini R, Qiu MR, Warton K, Musgrove EA, et al. The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle. J Physiol 2000; 529: 541-552.
  7. Xu Y, Zhu J, Hu X, Wang C, Lu D, Gong C, et al. CLIC1 inhibition attenuates vascular inflammation, oxidative stress, and endothelial injury. PLoS One 2016; 11: e0166790.
  8. Guo D, Xie W, Xiong P, Li H, Wang S, Chen G, et al. Cyclin-dependent kinase 5-mediated phosphorylation of chloride intracellular channel 4 promotes oxidative stress-induced neuronal death. Cell Death Dis 2018; 9: 951.
  9. Zhang L, Chen X, Yao S, Zheng L, Yang X, Wang Y, et al. Intracellular chloride channel 1 and tumor. Am J Cancer Res 2023; 13: 3300-3314.
  10. Ozaki S, Mikami K, Kunieda T, Tanaka J. Chloride intracellular channel proteins (CLICs) and malignant tumor progression: a focus on the preventive role of CLIC2 in invasion and metastasis. Cancers (Basel) 2022; 14: 4890.
  11. Li X, Wang Y, Ren M, Liu Q, Li J, Zhang L, et al. The role of chloride intracellular channel 4 in tumors. Cancer Cell Int 2025; 25.
  12. Wojtera BP, Ostrowska K, Szewczyk M, Masternak MM, Golusiń- ski W. Chloride intracellular channels in oncology as potential novel biomarkers and personalized therapy targets: a systematic review. Rep Pract Oncol Radiother 2024: 29: 258-270.
  13. Huang J-J, Lin J, Chen X, Zhu W. Identification of chloride intracellular channels as prognostic factors correlated with immune infiltration in hepatocellular carcinoma using bioinformatics analysis. Medicine 2021; 100: e27739.
  14. Magouliotis DE, Sakellaridis N, Dimas K, Tasiopoulou VS, Svo- kos KA, Svokos AA, et al. In silico transcriptomic analysis of the chloride intracellular channels (CLIC) interactome identifies a molecular panel of seven prognostic markers in patients with pancreatic ductal adenocarcinoma. Curr Genomics 2020; 21: 119-127.
  15. Huang Q, Lv Q, Tang W, Pan Y, Xing Y, He M, et al. A comprehensively prognostic and immunological analysis of chloride intracellular channel protein 5 (CLIC5) in pan-cancer and identification in ovarian cancer. J Cancer Res Clin Oncol 2023; 149: 10561-10583.
  16. Wang H, An J, He S, Liao C, Wang J, Tuo B. Chloride intracellular channels as novel biomarkers for digestive system tumors (review). Mol Med Rep 2021; 24: 630.
  17. Wang J, Wang Y, Ma H, Li Y, Hou J, Li J, et al. CLIC6’s role in cancer: from broad analysis to breast cancer validation. Front Oncol 2025; 15: 1667589.
  18. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.
  19. Guo K, Xiao W, Chen X, Zhao Z, Lin Y, Chen GE. Epidemiological trends of head and neck cancer: a population‐based study. Biomed Res Int 2021; 2021: 1738932.
  20. Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J 2022; 233: 780-786.
  21. Machiels J-P, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V, et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020; 31: 1462-1475.
  22. Fasano M, Corte CMD, Liello RD, Viscardi G, Sparano F, Iacovino ML, et al. Immunotherapy for head and neck cancer: present and future. Crit Rev Oncol Hematol 2022; 174: 103679.
  23. Mehanna H, Taberna M, Von Buchwald C, Tous S, Brooks J, Mena M, et al. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol 2023; 24: 239-251.
  24. Blažek T, Petráš M, Knybel L, Cvek J, Soumarová R. Programmed cell death ligand 1 expression on immune cells and survival in patients with nonmetastatic head and neck cancer: a systematic review and meta-analysis. JAMA Netw Open 2023; 6: e236324.
  25. Wojtera BP, Ostrowska K, Ostapowicz J, Szewczyk M, Kozikowska J, Suchorska WM, et al. The pursuit of novel head and neck cancer biomarkers – tissue and blood expression of chloride intracellular channels family. PLoS One 2025; 20: e0333487.
  26. Wojtera B, Sobecka A, Szewczyk M, Machczyński P, Suchorska WM, Golusiński W. CLIC1 plasma concentration is associated with lymph node metastases in oral squamous cell carcinoma. Adv Clin Exp Med 2022; 32: 341-347.
  27. Xu Y, Xu J, Feng J, Li J, Jiang C, Li X, et al. Expression of CLIC1 as a potential biomarker for oral squamous cell carcinoma: a preliminary study. Onco Targets Ther 2018; 11: 8073-8081.
  28. Feng J, Xu J, Xu Y, Xiong J, Xiao T, Jiang C, et al. CLIC1 promotes the progression of oral squamous cell carcinoma via integrins/ERK pathways. Am J Transl Res 2019; 11: 557-571.
  29. Lima FJ, Lopes MLDDS, Barros CCDS, Weege Nonaka CF, Dantas da Silveira EJ. Modification in CLIC4 expression is associated with P53, TGF-, TNF- and myofibroblasts in lip carcinogenesis. Braz Dent J 2020; 31: 290-297.
  30. Karsani S, Saihen N, Zain R, Cheong SC, Rahman MA. Comparative proteomics analysis of oral cancer cell lines: identification of cancer associated proteins. Proteome Sci 2014; 12: 3.
  31. Cristofaro MG, Scumaci D, Fiumara CV, di Sanzo M, Zuccalà V, Donato G, et al. Identification of prognosis-related proteins in gingival squamous cell carcinoma by twodimensional gel electrophoresis and mass spectrometry-based proteomics. Ann Ital Chir 2014; 85: 518-524.
  32. Xue H, Lu J, Yuan R, Liu J, Liu Y, Wu K, et al. Knockdown of CLIC4 enhances ATP-induced HN4 cell apoptosis through mitochondrial and endoplasmic reticulum pathways. Cell Biosci 2016; 6: 5.
  33. Chang YH, Wu CC, Chang KP, Yu JS, Chang YC, Liao PC. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. J Proteome Res 2009; 8: 5465-5474.
  34. Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol 2020; 38: 675-678.
  35. Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 2022; 25: 18-27.
  36. Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 2017; 19: 649-658.
  37. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science 2015; 347: 1260419.
  38. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-404.
  39. De Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, et al. Analysis and visualization of longitudinal genomic and clini­cal data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res 2023; 83: 3861-3867.
  40. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.
  41. Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres- Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013; 4: 2612.
  42. Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 2019; 35: 4200-4202.
  43. Kim J-S, Chang JW, Yun HS, Yang KM, Hong EH, Kim DH, et al. Chloride intracellular channel 1 identified using proteomic analysis plays an important role in the radiosensitivity of HEp-2 cells via reactive oxygen species production. Proteomics 2010; 10: 2589-2604.
  44. Zhu L, Chen Q, Zhang L, Hu S, Zheng W, Wang C, et al. CLIC4 regulates radioresistance of nasopharyngeal carcinoma by iNOS after -rays but not carbon ions irradiation. Am J Cancer Res 2020; 10: 1400-1415.
  45. Wang K, Chen Z, Long L, Tao Y, Wu Q, Xiang M, et al. iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma. Cancer Biol Ther 2018; 19: 809-824.
  46. Liu C, Ni C, Li C, Tian H, Jian W, Zhong Y, et al. Lactate-related gene signatures as prognostic predictors and comprehensive analysis of immune profiles in nasopharyngeal carcinoma. J Transl Med 2024; 22: 1116.
  47. Wang Z, Ling S, Rettig E, Sobel R, Tan M, Fertig EJ, et al. Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration. Oral Oncol 2015; 51: 1120-1125.
  48. Romanowska K, Sobecka A, Rawłuszko-Wieczorek AA, Suchor- ska WM, Golusiński W. Head and neck squamous cell carcinoma: epigenetic landscape. Diagnostics 2020; 11: 34.
  49. Liouta G, Adamaki M, Tsintarakis A, Zoumpourlis P, Liouta A, Agelaki S, et al. DNA methylation as a diagnostic, prognostic, and predictive biomarker in head and neck cancer. Int J Mol Sci 2023; 24: 2996.
  50. Chiliquinga AJ, Acosta B, Ogonaga-Borja I, Villarruel-Melquiades F, de la Garza J, Gariglio P, et al. Ion channels as potential tools for the diagnosis, prognosis, and treatment of HPV-associated cancers. Cells 2023; 12: 1376.
  51. Han Y, Shi Y, Chen B, Wang J, Liu Y, Sheng S, et al. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: prognostic assessment and treatment guidance. Front Immunol 2022; 13: 961695.
  52. Lin J, Wang X, Ma S, Yang D, Li K, Li D, et al. Calcium channels as therapeutic targets in head and neck squamous cell carcinoma: current evidence and clinical trials. Front Oncol 2024; 14: 1516357.
  53. González-González R, Ortiz-Sarabia G, Molina-Frechero N, Salas- Pacheco JM, Salas-Pacheco SM, Lavalle-Carrasco J, et al. Epithelial- mesenchymal transition associated with head and neck squamous cell carcinomas: a review. Cancers 2021; 13: 3027.
  54. Frederick M, Skinner HD, Kazi SA, Sikora AG, Sandulache VC. High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung. Sci Rep 2020; 10: 6380.
  55. Cole DW, Svider PF, Shenouda KG, Lee PB, Yoo NG, McLeod TM, et al. Targeting the unfolded protein response in head and neck and oral cavity cancers. Exp Cell Res 2019; 382: 111386.
  56. Bani-Ahmad E, Dass J, Dass CR. From carcinogenesis to drug resistance: the multifaceted role of oxidative stress in head and neck cancer. Cancers 2025; 17: 3295.
  57. The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015; 517: 576-582.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees